Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GUSBP5, also known as Glucuronidase beta pseudogene 5, is a processed pseudogene closely related to the canonical “Glucuronidase beta (GUSB)” gene. It lacks canonical protein-coding potential, with no evidence for functional protein-coding capability, and does not encode a functional enzyme. As a processed pseudogene, it is derived from the retrotransposition of mRNA, lacks introns, and typically does not express proteins in vivo, resembling a known gene but being nonfunctional due to disabling mutations or lack of regulatory elements. The parental GUSB gene encodes an active lysosomal enzyme, a function GUSBP5 does not share. There are no known independent biological or pathological functions in humans, nor any reported disease associations, drug interactions, or safety/therapeutic considerations because it has no confirmed protein product or activity. While GUSBP5 shows expression patterns in some tissues and may have limited roles in gene regulation (e.g., as a non-coding RNA), no direct biological or clinical relevance has been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucuronidase beta pseudogene 5 (GUSBP5).